Resmed (RMD) Change in Accured Expenses (2009 - 2026)

Resmed (RMD) has 18 years of Change in Accured Expenses data on file, last reported at $103.9 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 64.65% year-over-year to $103.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $171.2 million (up 4.52% YoY) and the FY2025 annual result came in at $91.0 million, down 25.49% from the prior year.
• Change in Accured Expenses rose to $103.9 million in Q1 2026, from $10.6 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $122.0 million in Q2 2024 to a low of -$34.4 million in Q4 2023.
• A 5-year average of $25.0 million and a median of $10.6 million in 2025 frame the typical range for Change in Accured Expenses.
• The widest YoY moves for Change in Accured Expenses: up 36862.42% in 2024, down 2399.02% in 2024.
• Tracing RMD's Change in Accured Expenses over 5 years: stood at -$17.3 million in 2022, then tumbled by 99.02% to -$34.4 million in 2023, then soared by 112.28% to $4.2 million in 2024, then surged by 152.25% to $10.6 million in 2025, then jumped by 875.82% to $103.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $103.9 million (Q1 2026), $10.6 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.